A Study of DM005 in Patients With Advanced Solid Tumors

NCT06515990 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

136

Enrollment

INDUSTRY

Sponsor class

Conditions

Carcinoma, Non-Small-Cell Lung
Squamous Cell Carcinoma of Head and Neck
Solid Carcinoma

Interventions

DRUG: DM005

Sponsor

Doma Biopharmaceutical（Suzhou）Co., Ltd.